Supplement Defect Action Levels To Follow GMP Reg - FDAer
This article was originally published in The Tan Sheet
Executive Summary
The establishment of defect action levels (DALs) for dietary supplement ingredients likely will be handled separately from FDA's pending proposed rule on Good Manufacturing Practice standards for supplements, FDA Consumer Safety Officer Karen Strauss told small business reps at a GMPs meeting in Salt Lake City, Utah Sept. 28.
You may also be interested in...
Single Identity Test For Botanicals "Makes Sense" - Israelsen
The use of multiple tests to confirm the identity of botanical ingredients is inappropriate, especially for small manufacturers of dietary supplements, Utah Natural Products Alliance Executive Director Loren Israelsen told FDAers at a public meeting on supplement GMPs in Salt Lake City, Utah Sept. 28.
Single Identity Test For Botanicals "Makes Sense" - Israelsen
The use of multiple tests to confirm the identity of botanical ingredients is inappropriate, especially for small manufacturers of dietary supplements, Utah Natural Products Alliance Executive Director Loren Israelsen told FDAers at a public meeting on supplement GMPs in Salt Lake City, Utah Sept. 28.
Single Identity Test For Botanicals "Makes Sense" - Israelsen
The use of multiple tests to confirm the identity of botanical ingredients is inappropriate, especially for small manufacturers of dietary supplements, Utah Natural Products Alliance Executive Director Loren Israelsen told FDAers at a public meeting on supplement GMPs in Salt Lake City, Utah Sept. 28.